Pre-Clinical Testing → In Vitro and In Vivo Models for Pre-Clinical Studies

The efficacy and toxicity data obtained from pre-clinical in vitro and in vivo studies form the basis for clinical trials. For in vitro studies, immortalized cell lines, primary cells isolated from animal/human tissues, and stem cells are regularly used. For in vivo studies, laboratory mice and rats are routinely used. Animal disease models are often established in mice and rats by (a) introducing human diseases genes associated with the disease into the animal, or (b) a disease can be modelled via injecting the animal with a defined chemical. To ensure the relevance of the pre-clinical data to a human disease, in vitro and in vivo models have to be selected carefully.
A comparison between human primary cells and cell lines
| Human Primary Cells | Cell Lines | |||
| Culture |
requires special media or additives (e.g., growth factors); low-serum or serum-free media/standardized culture conditions; culture conditions need to be adjusted for each cell type |
standard media; standard culture conditions |
||
| Handling | require more cell culture skills, careful planning, and are sensitive to mistreatment | easy to work with, easy to keep alive | ||
| Costs | higher | lower | ||
| Cell availability | limited | unlimited | ||
| Senescence | cells have limited self-renewal | cells can be grown and expanded over longer periods of time | ||
| Identity | donor characteristics are defined, cells retain the characteristics of the tissue of origin | questionable, misidentification possible | ||
| Reproducibility of results | lower, donor-to-donor variations need to be considered | higher, uniform cell type | ||
| Ethics | ethical regulations associated to the use of human tissue have to be considered | no need of human tissue | ||
| Morphology | show healthy cell morphology | loss of polarity, lack of key morphology features | ||
| Phenotype | maintain original phenotype for a limited number of passages depending on cell type and culture conditions | changes in phenotype (need to be validated!), functional alterations | ||
| Genome | genetically stable | altered genomic content | ||
| Contaminations | general contamination, cross-contamination with other cells, mycoplasma contamination, endotoxins need to be tested, antibiotics can influence cell metabolism | general contamination, cross-contamination with other cells, mycoplasma contamination, antibiotics can influence cell metabolism | ||
| Relevance in vivo | high | low (some cell lines show only marginal similarity to original primary cell phenotype) | ||
| Quality standards | standardized quality control and documentation is necessary | phenotype needs to be validated | ||
|
Source: https://www.promocell.com/f/2019/10/Table_Human-primary-cells-and-cell-lines_0.jpg |
||||
Some examples of animal models
- APP/PS1 mouse model of Alzheimer’s disease, https://www.alzforum.org/research-models/appps1
- MPTP mice model of Parkinson’s disease, https://www.nature.com/articles/nprot.2006.342